Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |
Description of the financial instrument, type of instrument
|
Smith & Nephew plc SPON ADR American Depositary Shares (ADS)
|
Identification code
|
ISIN: US83175M2052
|
Nature of the transaction
|
PDMR is a participant of the Company's Employee Stock Purchase Plan, which purchased American Depository Shares through the Company's Dividend Re-Investment Plan following the 2020 final dividend payment on 12 May 2021.
|
Date of Transaction
|
2021 - 05 - 14
|
Place of Transaction
|
New York Stock Exchange
|
Name (Position)
|
Director / PDMR
|
Price ($)
|
Volume
|
Aggregated information
|
Total Ordinary Share Holding following the transaction *
|
Total Ordinary Share Holding as a % of the Company's ISC following the transaction *
|
Bradley Cannon
(President Sports Medicine & ENT)
|
PDMR
|
42.9981
|
22.0926
|
N/A Single Transaction
|
77,339.58864 (including 2,123.73810 in ADS')
|
0.00874%
|
Catheryn O'Rourke
(Chief Legal & Compliance Officer)
|
PDMR
|
42.9981
|
61.16201
|
N/A Single Transaction
|
82,222.87749 (including 5,879.41935 in ADS')
|
0.00929%
|
Attachments
- Original document
- Permalink
Disclaimer
Smith & Nephew plc published this content on 18 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 May 2021 17:17:07 UTC.